📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Phase I Study Evaluating the Safety and Persistence of Allorestricted WT1-TCR Gene Modified Autologous T Cells in Patients with High-Risk Myeloid Malignancies Unsuitable for Allogeneic Stem Cell Transplantation (2019)

First Author: Morris E

Attributed to: Precision targeting of mTOR in conventional and MHC class I-restricted anti-tumour CD4+ T cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2019-128044

Publication URI: http://dx.doi.org/10.1182/blood-2019-128044

Type: Journal Article/Review

Parent Publication: Blood

Issue: Supplement_1